TonyGEasley
117 views | +0 today
Follow
 
Scooped by Tony G. Easley
onto TonyGEasley
Scoop.it!

Another Hollywwod Celeb Droping HUGE weight

How Did Miranda Lambert Lose All This Weight? People are going crazy over how fast Miranda Lambert dropped over 30+ pounds. I have to admit, I was shocked myself. When she showed up at the CMT music awards jaws were dropping left and right. Even though the award show was a couple weeks ago, I still haven't been able to get how good she looked out of my head. She looked stunning sporting an open cut chest to stomach sexy and powerful dress. I figured some other redditor's would be thinking the same thing that I did....How did she lose all that weight? http://www.reddit.com/r/GarciniaCambogiaTrial/comments/2mpptp/miranda_lamberts_weight_loss_story/
more...
No comment yet.
Your new post is loading...
Your new post is loading...
Scooped by Tony G. Easley
Scoop.it!

EnvisionTEC and 3Shape Offer Turnkey System to 3D Scan and Print In-Ear Devices

DEARBORN, Mich. & COPENHAGEN, Denmark--(BUSINESS WIRE)--#3dprinting--EnvisionTEC and 3Shape Offer Turnkey System to 3D Scan and Print In-Ear Devices
more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Sosei Subsidiaries Heptares to Acquire G7 Therapeutics to Extend Leadership in GPCR-focused Drug Discovery and Development

TOKYO--(BUSINESS WIRE)--Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces that Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei, has signed a share purchase agreement that will allow the acquisition of 100% in G7 Therapeutics, a privately held drug discovery and development company based in Switzerland, for CHF 12 million cash. The strategic acquisition broadens and strengthens Heptares' intellectual property and platform for structure-based dr

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

U.S. Senator Bernie Sanders Hosts San Francisco Rally TODAY-Oct. 15th-for Lower Drug Price Initiative, Yes on Prop 61

SAN FRANCISCO--(BUSINESS WIRE)--U.S. Senator Bernie Sanders Hosts San Francisco Rally TODAY-Oct. 15th-for Lower Drug Price Initiative, Yes on Prop 61

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Virginia Governor Terry McAuliffe Presented 2016 BIO Governor of the Year Award

SAN FRANCISCO--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today presented Virginia Governor Terry McAuliffe with its 2016 Governor of the Year award in recognition of his leadership and commitment to strengthening the biosciences industry within Virginia. Governor McAuliffe received the award at the 2016 BIO International Convention. “Biotech innovation is key to building a new Virginia economy, and we have made it a top priority to encourage growth in this exciting sector

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

ADDING and REPLACING RxC International to Lead Gene Therapy Panel at NewYorkBIO Annual Conference May 11 - 12, 2016

MORRISTOWN, N.J.--(BUSINESS WIRE)--RxC International Senior Partner Richard Tinsley will lead a panel on gene therapy featuring life science leaders and experts at the NewYorkBIO annual conference in New York City, May 11-12, 2016

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Samenvatting: Het Center for iPS Cell Research and Application van Kyoto University en Takeda lanceren samenwerking op het gebied van iPS-stamceltoepassing

KYOTO & OSAKA, Japan--(BUSINESS WIRE)--Het Center for iPS Cell Research and Application (CiRA) van de Kyoto University en Takeda Pharmaceutical Company Limited (Takeda) hebben vandaag het begin aangekondigd van een gezamenlijk onderzoeksprogramma naar de klinische toepassing van aangemaakte pluripotente stamcellen (iPS). Het “Takeda-CiRA Joint Program for iPS Cell Applications” (T-CiRA) zal onderzoek doen naar zes hoofdonderwerpen om de mogelijkheden van klinische toepassingen van stamcellen vo

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1, 4 or 6 Infec...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

UnitedHealthcare and Optum Act to Support People Affected by Wenatchee Wildfires

MINNETONKA, Minn.--(BUSINESS WIRE)--UnitedHealthcare and Optum are taking action to help people affected by the recent wildfires affecting residents in Wenatchee and to the northwest in the neighborhood of Sleepy Hollow Heights.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Dicerna Presents Preliminary Safety and Efficacy Data from DCR-MYC Phase 1 Study in Patients with Advanced Solid Tumors at the 2015 ASCO Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna presented preliminary safety and efficacy data from an ongoing Phase 1 study of DCR-MYC in patients with advanced solid tumors, multiple myeloma, or lymphoma at the 2015 ASCO Annual Meeting.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Advanced Non-Small Cell Lung Cancer, and Grants Priority Review

KENILWORTH, N.J.--(BUSINESS WIRE)--FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Advanced Non-Small Cell Lung Cancer, and Grants Priority Review

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a Company Structured to Accelerate Therapeutic Innovation

DEERFIELD, Ill. & ROCHESTER, Minn. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Baxter Ventures, Mayo Clinic, and Velocity Pharmaceutical Development announce the formation of Vitesse Biologics, LLC, a company structured to accelerate therapeutic innovation.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Transgene annonce la présentation à l’ASCO de nouvelles données positives de la phase 2b de l’étude TIME avec TG4010, son produit d’immunothérapie, en cancer du poumon non à petites cellules

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene SA (Euronext : TNG) annonce aujourd’hui la présentation1, lors du congrès annuel de l’association américaine d’oncologie clinique (ASCO - American Society of Clinical Oncology) qui se tient à Chicago, aux Etats-Unis, de nouvelles données de la phase 2b de l’étude TIME de TG4010, produit d’immunothérapie ciblée contre MUC1, en cancer du poumon « non à petites cellules ». Ces données plus matures confirment la solidité des améliorati

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

CORRECTING and REPLACING Quintiles Officially Opens Greater China Regional Headquarters in Shanghai

SHANGHAI--(BUSINESS WIRE)--More than 30 leaders from China’s government and healthcare communities joined Quintiles executives in Shanghai today to officially open Quintiles' Greater China Regional Headquarters.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Celgene recebe parecer positivo da CHMP para expandir a indicação de REVLIMID® (lenalidomida) como monoterapia para o tratamento de manutenção em pacientes com Mieloma Múltiplo (MM) recém-diagnosti...

BOUDRY, Suíça--(BUSINESS WIRE)--Celgene International Sàrl, uma subsidiária integral da Celgene Corporation (NASDAQ:CELG), anunciou hoje que o Comitê de Medicamentos para Uso Humano (CHMP) da Agência Europeia de Medicamentos (EMA) emitiu um parecer positivo para o uso de REVLIMID® como monoterapia para o tratamento de manutenção de pacientes adultos com mieloma múltiplo (MM) recém-diagnosticados que foram submetidos a transplante autólogo de células estaminais (TACE). Uma vez aprovado pela Comi
more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Freeway Insurance to Offer Free Health Insurance Enrollment Services During 2016-2017 Open Enrollment

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Freeway Insurance announced today that it will again offer free bilingual health insurance enrollment services in over 160 stores across CA during the Open Enrollment period for 2016-2017.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Campanha de pureza da água promovida pela AQUA Carpatica vence em sua categoria no D&AD Impact

NOVA YORK--(BUSINESS WIRE)--A AQUA Carpatica, a única água mineral do mundo naturalmente isenta de nitratos, tem a satisfação de anunciar que a marca foi premiada com um Lápis Branco na categoria Comunicação e Interação durante o primeiro evento D&AD Impact de premiação em comunicação, realizado na cidade de Nova York. O prêmio máximo concedido à campanha “Teste de Pureza” da AQUA Carpatica celebra o uso que a marca faz da criatividade como uma força pela melhoria do mundo. A Romênia possui

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Synergy Pharmaceuticals Presents Additional Phase 3 Plecanatide Data in Chronic Idiopathic Constipation at Digestive Disease Week

NEW YORK--(BUSINESS WIRE)--#DDW16--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced additional data from two pivotal phase 3 clinical trials (Study-00 and Study-03) evaluating the efficacy and safety of plecanatide, a once-daily oral tablet, in treating patients with chronic idiopathic constipation (CIC). Data were presented at Digestive Disease Week (DDW) in San Diego. The primary endpoint for both pivotal trials was the durable overall complete spontaneous bowel movement (CSBM) responder en

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

STAT-Diagnostica Announces 25 Million Euros in Series C Financing Led by Gilde Healthcare

BARCELONA, Spain--(BUSINESS WIRE)--Medical diagnostics company STAT-Diagnostica has closed a Series C financing round totaling 25 million Euros/28.5 million USD. The proceeds will be used to launch its DiagCORE system.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Research and Markets: Canada Microbiology Culture Market Outlook 2015-2021

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v8fzkt/canada) has announced the addition of the "Canada Microbiology Culture Market Outlook to 2021" report to their offering. "Canada Microbiology Culture Market Outlook to 2021", provides key market data on the Canada Microbiology Culture market. The report provides value, in millions of US dollars within market segments - Microbiology Analyzers, Mycobacteria Culture, Blood Culture, Bacterial Identifica

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Astex Pharmaceuticals Announces Publication of Key Clinical Data for Guadecitabine (SGI-110) in The Lancet Oncology

PLEASANTON, Calif.--(BUSINESS WIRE)--Astex Pharmaceuticals Announces Publication of Key Clinical Data for Guadecitabine (SGI-110) in The Lancet Oncology

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Victory Parent Company, LLC and Four Texas Medical Centers Voluntarily File Under Chapter 11 to Preserve Value, Effect Asset Sales

THE WOODLANDS, Texas--(BUSINESS WIRE)--Victory Parent Company, LLC (“Victory”), which manages six for-profit Victory Healthcare medical and surgical centers in Texas, today filed voluntarily under Chapter 11 of the U.S. Bankruptcy Code in the Northern District of Texas in Fort Worth. Concurrently, Victory intends to file a motion for an accelerated sale of its Victory Medical Center in Plano, Tex. to Nobilis, which recently purchased the company’s Victory Medical Center Houston in the Texas Med

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

The Patient Recruiting AgencyTM Announces a Clinical Research Study for Lupus Nephritis

AUSTIN, Texas--(BUSINESS WIRE)--Enhanced recruitment initiated for a research study of an investigational drug for lupus nephritis.

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

New Project Urges Political Action to Support America’s Family Caregivers

ANN ARBOR, Mich.--(BUSINESS WIRE)--The Family Caregiver Platform Project has launched a national campaign to get family caregiving issues included in state political party platforms across the United States. The nonpartisan project reaches out to individual volunteers and organizations to raise awareness of caregiving issues. A new website, CaregiverCorps.org, will coordinate grassroots efforts to educate and motivate state and national policymakers to improve support for family caregivers and

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

Recipharm AB: Recipharm appoints Chief Strategy Officer

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Recipharm, (STO: RECI) the leading contract development and manufacturing organisation, is pleased to announce that it has appointed Jean-François Hilaire to the new position of Chief Strategy Officer to join Recipharm’s Group Management Team with effect from today. Jean-François Hilaire is a pharmacist and graduated from the university of Bordeaux and alumni of the CEDEP General Manager Program (campus INSEAD – Fontainebleau). He brings a broad expe

more...
No comment yet.
Scooped by Tony G. Easley
Scoop.it!

昆泰正式于上海开设大中华区总部

上海--(BUSINESS WIRE)--今天,30余名中国政府官员和医疗保健业内领袖与昆泰高管一同出席了昆泰大中华区地区总部的官方开业仪式,进一步扩大其帮助中国公司在全球范围内进行扩张,以及帮助跨国公司在全球第二大生物制药市场成功开展业务的能力。17年前,昆泰于上海开设首家办事处。 昆泰创始人兼执行董事长Dennis Gillings, CBE博士在上海枫林科技园举行的开业典礼上表示:“今天的开幕仪式不仅体现出昆泰的成长,同样彰显出大中华区在生物制药研发行业的全球领先地位。20年前我们在上海开设办事处时,我们在整个大中华区有20名员工,如今,员工人数已突破1,000名。如今,我比以往都更加确信,今天汇集于此的领导们的共同愿景定将实现,即让上海和大中华区成为生物制药研发和医疗保健行业的全球创新中心。” 上海徐汇区副区长王宏舟与Gillings博士共同在开幕仪式上发表了演讲。 王区长表示:“长期以来,昆泰一直是我们珍视的医疗保健行业伙伴和顾问。枫林科技园是我们努力吸纳学术和行业领袖并打造创新和合作中心这项工作的核心。我们期待与昆泰继续合作,整合科学、技术和医疗保健以拯救生命并减轻病痛。

more...
No comment yet.